Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

20204,426 citationsReviewgold Open Access

Authors

Jing Yang · First Hospital of Lanzhou University

Ya Zheng · First Hospital of Lanzhou University

Xi Gou · First Hospital of Lanzhou University

Ke Pu · First Hospital of Lanzhou University

Zhaofeng Chen · First Hospital of Lanzhou University

Qinghong Guo · First Hospital of Lanzhou University

Rui Ji

Abstract

We assessed the prevalence of comorbidities in the COVID-19 patients and found that underlying disease, including hypertension, respiratory system disease and cardiovascular disease, may be risk factors for severe patients compared with non-severe patients.

Topics & Keywords

COVID-19 Clinical Research Studies Long-Term Effects of COVID-19 SARS-CoV-2 and COVID-19 Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Infectious Diseases

Volume 94, pp. 91-95

DOI: 10.1016/j.ijid.2020.03.017

Field-Weighted Citation Impact: 103.48